Antibody–drug nanoparticle induces synergistic treatment efficacies in HER2 positive breast cancer cells

Abstract Chemotherapeutic drugs suffer from non-specific binding, undesired toxicity, and poor blood circulation which contribute to poor therapeutic efficacy. In this study, antibody–drug nanoparticles (ADNs) are engineered by synthesizing pure anti-cancer drug nanorods (NRs) in the core of nanopar...

Full description

Saved in:
Bibliographic Details
Main Authors: Muhammad Raisul Abedin, Kaitlyne Powers, Rachel Aiardo, Dibbya Barua, Sutapa Barua
Format: article
Language:EN
Published: Nature Portfolio 2021
Subjects:
R
Q
Online Access:https://doaj.org/article/f71113ad9cc246b795e2a4ade2f68097
Tags: Add Tag
No Tags, Be the first to tag this record!